EGFR and neoplasm: In another study, VHHs interacted with EGFR tyrosine kinase residues in the vicinity of their catalytic area (the part to which the natural ligand binds) by using CDR3 and thereby hindered the function of EGFR, impeding tumor cell proliferation and migration (126).